BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18842233)

  • 21. Molecular and phenotypic characterization of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases with focus on CTX-M in a low-endemic area in Sweden.
    Onnberg A; Mölling P; Zimmermann J; Söderquist B
    APMIS; 2011 Apr; 119(4-5):287-95. PubMed ID: 21492229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from hospitals in Lithuania.
    Šeputienė V; Linkevičius M; Bogdaitė A; Povilonis J; Plančiūnienė R; Giedraitienė A; Pavilonis A; Sužiedėlienė E
    J Med Microbiol; 2010 Oct; 59(Pt 10):1263-1265. PubMed ID: 20576750
    [No Abstract]   [Full Text] [Related]  

  • 23. Hospital environmental contamination with Enterobacteriaceae producing extended-spectrum β-lactamase.
    Gbaguidi-Haore H; Talon D; Hocquet D; Bertrand X
    Am J Infect Control; 2013 Jul; 41(7):664-5. PubMed ID: 23337304
    [No Abstract]   [Full Text] [Related]  

  • 24. Extended spectrum beta lactamase (ESBL) producing Escherichia coli and klebsiella pneumoniae in diabetic foot infection.
    Varaiya A; Dogra J; Kulkarni M; Bhalekar P
    Indian J Med Microbiol; 2008; 26(3):281-2. PubMed ID: 18695337
    [No Abstract]   [Full Text] [Related]  

  • 25. [Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae].
    de Cueto M; Hernández JR; López-Cerero L; Morillo C; Pascual A
    Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):613-6. PubMed ID: 17194386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum beta-lactamase (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes.
    Apisarnthanarak A; Kiratisin P; Mundy LM
    Infect Control Hosp Epidemiol; 2008 Nov; 29(11):1026-34. PubMed ID: 18947321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predominance of CTX-M-15 extended spectrum beta-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait.
    Ensor VM; Jamal W; Rotimi VO; Evans JT; Hawkey PM
    Int J Antimicrob Agents; 2009 May; 33(5):487-9. PubMed ID: 19097760
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevalence and susceptibility patterns of extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in a general university hospital in Beirut, Lebanon].
    Daoud Z; Hakime N
    Rev Esp Quimioter; 2003 Jun; 16(2):233-8. PubMed ID: 12973463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae producing NDM-1 in Lebanon.
    El-Herte RI; Araj GF; Matar GM; Baroud M; Kanafani ZA; Kanj SS
    J Infect Dev Ctries; 2012 May; 6(5):457-61. PubMed ID: 22610714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a comprehensive cancer center in Japan, 2009-2013.
    Kawamura I; Ohmagari N; Tsukahara M; Kudo T; Kurai H
    Am J Infect Control; 2015 Feb; 43(2):185-7. PubMed ID: 25530558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful control of the first OXA-48 and/or NDM carbapenemase-producing Klebsiella pneumoniae outbreak in Slovenia 2014-2016.
    Pirš M; Cerar Kišek T; Križan Hergouth V; Seme K; Mueller Premru M; Jeverica S; Logar M; Mrvič T; Žnidaršič B; Jordan Markočič O; Lejko Zupanc T
    J Hosp Infect; 2019 Feb; 101(2):142-149. PubMed ID: 30399389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissemination of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli in Thai hospitals.
    Niumsup PR; Tansawai U; Boonkerd N; Polwichai P; Dejsirilert S
    J Infect Chemother; 2008 Dec; 14(6):404-8. PubMed ID: 19089552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of OXA-48-producing Enterobacteriaceae in Switzerland.
    Potron A; Schrenzel J; Poirel L; Renzi G; Cherkaoui A; Nordmann P
    Int J Antimicrob Agents; 2012 Dec; 40(6):563-4. PubMed ID: 23040008
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing intra-abdominal infections from 9 tertiary hospitals in China.
    Liao K; Chen Y; Wang M; Guo P; Yang Q; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Xu Y
    Diagn Microbiol Infect Dis; 2017 Jan; 87(1):45-48. PubMed ID: 27773544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ongoing increasing temporal and geographical trends of the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections in France, 2009 to 2013.
    Arnaud I; Maugat S; Jarlier V; Astagneau P;
    Euro Surveill; 2015; 20(36):. PubMed ID: 26536042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Shanthi M; Sekar U
    J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk factors associated with the isolation of extended spectrum betalactamases producing Escherichia coli or Klebsiella pneumoniae in a tertiary care hospital in Colombia].
    Jiménez A; Alvarado A; Gómez F; Carrero G; Fajardo C
    Biomedica; 2014 Apr; 34 Suppl 1():16-22. PubMed ID: 24968032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidemiological study on extended-spectrum beta-lactamase-producing in clinical isolates and selection of antibacterial drugs in China ].
    Yu YS
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1918-20. PubMed ID: 15631810
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular characterization of the β-lactamases in Escherichia coli and Klebsiella pneumoniae from a tertiary care hospital in Riyadh, Saudi Arabia.
    Marie MA; John J; Krishnappa LG; Gopalkrishnan S
    Microbiol Immunol; 2013 Dec; 57(12):805-10. PubMed ID: 24117831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for and outcomes of healthcare-associated infection due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae in Thailand.
    Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
    Infect Control Hosp Epidemiol; 2007 Jul; 28(7):873-6. PubMed ID: 17564993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.